Acute pain management

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• Subjective Uncoupling: The degree to which a patient experiences pain is a complex, subjective interaction between the physical stimulus and their cognitive and emotional state. The degree of perceived pain does not directly correlate with the degree of physiologic injury; patients with identical injuries may experience and display vastly different levels of pain.
• Pharmacokinetic Limitations: In the setting of renal dysfunction, the clearance of specific analgesics is impaired, making morphine dangerous and rendering nonsteroidal anti-inflammatory drugs (NSAIDs) contraindicated.
• Oligoanalgesia Risk: Undertreatment of pain (oligoanalgesia) remains a persistent systemic failure in emergency medicine, with specific mechanical breakdowns in care delivery disproportionately affecting ethnic minorities, the aged, the very young, and cognitively impaired patients.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

• Initial Assessment: Rapidly assess pain severity using a standardized 1-10 numeric rating scale, treating acute pain as an urgent condition that must be evaluated and managed concurrently with diagnostic workups.
• Mild to Moderate Pain:
• Administer Acetaminophen for mild pain.
• Administer NSAIDs for mild to moderate pain, alternating with acetaminophen, provided the patient does not have renal insufficiency.
• Apply basic supportive measures such as ice packs and elevation for affected extremities.
• Moderate to Severe Pain (Opioid Therapy):
• Morphine: 0.05 to 0.10 mg/kg IV (typically 2 to 5 mg IV in adults), administered every 15 to 20 minutes until the pain score is <4. Alternatively, 6 to 10 mg IV or 20 to 30 mg PO can be used initially.
• Hydromorphone: 1 to 2 mg IV or 2 to 4 mg PO.
• Titration: Reassess clinical response in 15 to 30 minutes; repeat with one-fourth to one-half of the initial dose if needed.
• Opioid-Sparing Adjuncts: Administer Ketamine in subdissociative doses to reduce opioid requirements, decrease treatment time, and lower overall pain scores.
• Renal Impairment Protocol: Morphine is not preferred. Use Fentanyl or Hydromorphone as the first-line IV opioid analgesics in patients with renal dysfunction.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

• "Can't-Miss" Differential Diagnoses:
• Vascular Emergencies: Abdominal Aortic Aneurysm (AAA) and acute mesenteric ischemia must be ruled out in older patients presenting with acute, severe abdominal or flank pain.
• Spinal Cord Emergencies: In patients with acute back pain, rule out epidural compression syndrome, cauda equina syndrome, spinal infections (epidural abscess), and occult spinal malignancies.
• Ectopic Pregnancy: Ruptured ectopic pregnancy must be considered in women of reproductive age presenting with acute abdominal or pelvic pain.
• Prioritized Diagnostic Workup:
• Vitals & Triage: Obtain a complete set of vital signs and a standard triage assessment on all patients, even those known to be frequent visitors with chronic pain.
• The Chronic vs. Acute Pivot: The primary diagnostic goal is to rapidly distinguish an exacerbation of a known chronic pain syndrome from a new life- or limb-threatening condition.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

• Point-of-Care Ultrasound (POCUS): In patients with undifferentiated severe abdominal or flank pain, immediately perform bedside ultrasound to evaluate for free intraperitoneal fluid or the presence of an Abdominal Aortic Aneurysm (AAA).
• Magnetic Resonance Imaging (MRI): Emergent MRI is the gold standard and is mandated for patients with acute back pain exhibiting "red flag" neurologic findings (e.g., gross muscle weakness, paralysis, bowel/bladder dysfunction) or high suspicion for spinal malignancy/infection.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

• Target Pain Score: Titrate intravenous analgesia iteratively to achieve a target pain score of <4 on the 1-10 numeric rating scale.
• Safe Opioid Prescribing Guidelines (CDC):
• Prescribe the lowest effective dose of immediate-release opioids only.
• Limit the prescription strictly to the expected duration of severe pain. Three days or less is usually sufficient; prescriptions exceeding seven days are rarely indicated.
• Back Pain Risk Stratification (Red Flags): Immediate escalation to advanced imaging and spine surgery consultation is required for pain associated with: trauma, unexplained weight loss, extremes of age, fever, IV drug use, prolonged steroid use, cancer history, or neurologic/urinary/bowel deficits.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

• Cognitive Trap (Withholding Analgesia): Refusing to administer opioids to a patient with severe abdominal pain out of fear that it will "mask" the physical examination. Early administration of analgesia actually improves patient comfort and increases the reliability of the physical exam.
• Cognitive Trap (Prejudging "Frequent Flyers"): Assuming a frequent ED visitor's pain is simply a chronic exacerbation or factitious. Staff must avoid this bias and always perform a full standard evaluation to avoid missing a new, emergent pathology.
• Cognitive Trap (The Iatrogenic Addiction): Prescribing prolonged courses of opioids upon discharge. Roughly 12% of opioid-naive patients given an ED prescription develop recurrent use, and approximately one-third of patients with opioid use disorder trace their first exposure to a legitimate ED prescription.
• Critical Action: Do not initiate or alter chronic pain regimens in the ED. Chronic pain treatment, particularly involving opioids, must only be undertaken in direct consultation with the outpatient clinician responsible for the patient's long-term management.

7. MCQ MASTERCLASS (Written Exam Tips)

• Buzzwords: "Numeric rating scale" = mandatory documentation tool. "Subdissociative ketamine" = opioid-sparing therapy.
• Classic Distractor: A question describes a patient with severe abdominal pain and a history of chronic renal failure, offering "Morphine 4 mg IV" as a treatment option. Correction: This is a dangerous distractor. Morphine is contraindicated/not preferred in renal insufficiency due to metabolite accumulation; the correct answer will be Fentanyl or Hydromorphone.
• Classic Distractor: A pregnant patient presents in severe pain, and the options suggest withholding pain medications to protect the fetus. Correction: Intravenous opioids (Morphine or Hydromorphone) are rapid, titratable, and generally considered safe in pregnancy.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

• The Initial Approach: "The patient is experiencing severe, acute pain. My immediate priority is to assess their ABCs and rule out life-threatening etiologies. I will order IV access and administer IV Morphine at 0.05 mg/kg, reassessing their numeric pain score every 15 minutes until it drops below 4. Because they have a history of chronic pain, I will evaluate for any new 'red flag' symptoms that deviate from their baseline."
• The Renal Pivot: "Given the patient's elevated creatinine and history of renal dysfunction, I will specifically avoid Morphine and NSAIDs. Instead, I will control their pain utilizing IV Fentanyl or Hydromorphone to avoid toxic metabolite accumulation."
• The Disposition Script: "The patient's acute life-threats have been ruled out. I will reassure the patient that their back pain is likely benign. I will not order an MRI as there are no red flag symptoms. I will discharge them with a short, 3-day prescription of immediate-release opioids in accordance with CDC guidelines, and instruct them to follow up with their primary care provider for any ongoing chronic pain management."